Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

Believing impossible things: achieving universal blood pressure awareness on a global basis.

Feldman RD, Campbell NRC.

Eur Heart J. 2019 Jun 17. pii: ehz413. doi: 10.1093/eurheartj/ehz413. [Epub ahead of print] No abstract available.

PMID:
31209462
2.

The History of Hypertension Guidelines in Canada.

Daskalopoulou SS, Feldman RD, McAlister FA, Rabi DM; Hypertension Canada.

Can J Cardiol. 2019 May;35(5):582-589. doi: 10.1016/j.cjca.2019.01.017. Epub 2019 Feb 2. Review.

PMID:
31030861
3.

Down the Rabbit Hole: Hypertension Guidelines, Goals and Gulfs Across the 49th Parallel.

Feldman RD.

Can J Cardiol. 2018 May;34(5):543-545. doi: 10.1016/j.cjca.2018.02.015. No abstract available.

PMID:
29731017
4.

Type 2 Diabetes and the Reduction of Cardiovascular Risk: Sorting Out the Actors and the Roles.

Feldman RD, Fitchett D, Hegele RA, Poulter NR.

Can J Cardiol. 2018 May;34(5):532-535. doi: 10.1016/j.cjca.2018.01.091. Epub 2018 Feb 6. No abstract available.

5.

Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children.

Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Padwal RS, Tran KC, Grover S, Rabkin SW, Moe GW, Howlett JG, Lindsay P, Hill MD, Sharma M, Field T, Wein TH, Shoamanesh A, Dresser GK, Hamet P, Herman RJ, Burgess E, Gryn SE, Grégoire JC, Lewanczuk R, Poirier L, Campbell TS, Feldman RD, Lavoie KL, Tsuyuki RT, Honos G, Prebtani APH, Kline G, Schiffrin EL, Don-Wauchope A, Tobe SW, Gilbert RE, Leiter LA, Jones C, Woo V, Hegele RA, Selby P, Pipe A, McFarlane PA, Oh P, Gupta M, Bacon SL, Kaczorowski J, Trudeau L, Campbell NRC, Hiremath S, Roerecke M, Arcand J, Ruzicka M, Prasad GVR, Vallée M, Edwards C, Sivapalan P, Penner SB, Fournier A, Benoit G, Feber J, Dionne J, Magee LA, Logan AG, Côté AM, Rey E, Firoz T, Kuyper LM, Gabor JY, Townsend RR, Rabi DM, Daskalopoulou SS; Hypertension Canada.

Can J Cardiol. 2018 May;34(5):506-525. doi: 10.1016/j.cjca.2018.02.022. Epub 2018 Mar 1.

PMID:
29731013
6.

Hypertension Guidelines in the United States and Canada: Are We Getting Closer?

Daskalopoulou SS, Rabi DM, Schiffrin EL, Feldman RD, Padwal RS, Tremblay G, Khan NA; Hypertension Canada.

Hypertension. 2018 Jun;71(6):976-978. doi: 10.1161/HYPERTENSIONAHA.117.10772. Epub 2018 Apr 23. No abstract available.

PMID:
29686013
7.

Single Pill Combinations as Initial Therapy in the Management of Hypertension: What is Taking you so Long?

Feldman RD.

Am J Hypertens. 2018 Feb 9;31(3):263-264. doi: 10.1093/ajh/hpx194. No abstract available.

PMID:
29228088
8.

Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults.

Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, Nerenberg K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tran KC, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GVR, Gryn SE, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Sivapalan P, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NRC, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Kline G, Leiter LA, Jones C, Côté AM, Woo V, Kaczorowski J, Trudeau L, Tsuyuki RT, Hiremath S, Drouin D, Lavoie KL, Hamet P, Grégoire JC, Lewanczuk R, Dresser GK, Sharma M, Reid D, Lear SA, Moullec G, Gupta M, Magee LA, Logan AG, Dionne J, Fournier A, Benoit G, Feber J, Poirier L, Padwal RS, Rabi DM; Hypertension Canada.

Can J Cardiol. 2017 May;33(5):557-576. doi: 10.1016/j.cjca.2017.03.005. Epub 2017 Mar 10. Erratum in: Can J Cardiol. 2017 Dec;33(12 ):1733-1734.

PMID:
28449828
9.
10.

Application of Hypertension Guidelines in the Elderly: Revisiting Where the Bridge to Nowhere Might Actually Be Going.

Feldman RD, Padwal RS.

Can J Cardiol. 2017 May;33(5):591-593. doi: 10.1016/j.cjca.2016.11.010. Epub 2016 Nov 15. No abstract available.

PMID:
28011109
11.

GPER (GPR30): A Nongenomic Receptor (GPCR) for Steroid Hormones with Implications for Cardiovascular Disease and Cancer.

Feldman RD, Limbird LE.

Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:567-584. doi: 10.1146/annurev-pharmtox-010716-104651. Epub 2016 Oct 21. Review.

PMID:
27814026
12.

Hypertension Attitude PersPEctives and Needs (HAPPEN): A Real-World Survey of Physicians and Patients With Hypertension in China.

Feldman RD, Liu L, Wu Z, Zhang Y, Yu X, Zhang XH.

J Clin Hypertens (Greenwich). 2017 Mar;19(3):256-264. doi: 10.1111/jch.12912. Epub 2016 Oct 26.

13.

Extent of Vascular Remodeling Is Dependent on the Balance Between Estrogen Receptor α and G-Protein-Coupled Estrogen Receptor.

Gros R, Hussain Y, Chorazyczewski J, Pickering JG, Ding Q, Feldman RD.

Hypertension. 2016 Nov;68(5):1225-1235. Epub 2016 Oct 3. Erratum in: Hypertension. 2016 Dec;68(6):e96.

PMID:
27698063
14.

Hypertension in Canada: Past, Present, and Future.

Schiffrin EL, Campbell NR, Feldman RD, Kaczorowski J, Lewanczuk R, Padwal R, Tobe SW.

Ann Glob Health. 2016 Mar-Apr;82(2):288-99. doi: 10.1016/j.aogh.2016.02.006. Review.

15.

Heart Disease in Women: Unappreciated Challenges, GPER as a New Target.

Feldman RD.

Int J Mol Sci. 2016 May 18;17(5). pii: E760. doi: 10.3390/ijms17050760. Review.

16.

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.

Leung AA, Nerenberg K, Daskalopoulou SS, McBrien K, Zarnke KB, Dasgupta K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Hiremath S, Drouin D, Lavoie KL, Hamet P, Fodor G, Grégoire JC, Lewanczuk R, Dresser GK, Sharma M, Reid D, Lear SA, Moullec G, Gupta M, Magee LA, Logan AG, Harris KC, Dionne J, Fournier A, Benoit G, Feber J, Poirier L, Padwal RS, Rabi DM; CHEP Guidelines Task Force.

Can J Cardiol. 2016 May;32(5):569-88. doi: 10.1016/j.cjca.2016.02.066. Epub 2016 Mar 10.

PMID:
27118291
17.

Applying Atherosclerotic Risk Prevention Guidelines to Elderly Patients: A Bridge Too Far?

Feldman RD, Harris SB, Hegele RA, Pickering JG, Rockwood K.

Can J Cardiol. 2016 May;32(5):598-602. doi: 10.1016/j.cjca.2016.02.002. Epub 2016 Feb 8.

PMID:
27040095
18.

Aldosterone mediates metastatic spread of renal cancer via the G protein-coupled estrogen receptor (GPER).

Feldman RD, Ding Q, Hussain Y, Limbird LE, Pickering JG, Gros R.

FASEB J. 2016 Jun;30(6):2086-96. doi: 10.1096/fj.15-275552. Epub 2016 Feb 24.

PMID:
26911792
19.

Hypertension in Canada and the Global Context. The Wine Is Vintage and the Glass Is Two-Thirds Full, but Is the Bottle Empty?

Campbell NR, Feldman RD.

Can J Cardiol. 2016 May;32(5):609-11. doi: 10.1016/j.cjca.2015.07.014. Epub 2015 Jul 28. No abstract available.

PMID:
26900109
20.

Are We Endangering Hypertensive Patients by Overzealous Treatment That Induces Diastolic Hypotension? A SPRINT to the Answer?

Feldman RD, Padwal RS.

Can J Cardiol. 2016 May;32(5):607-8. doi: 10.1016/j.cjca.2015.10.013. Epub 2015 Oct 24. No abstract available.

PMID:
26774234
21.

Copernicus Revisited: Overturning Ptolemy's View of the GPER Universe.

Feldman RD, Limbird LE.

Trends Endocrinol Metab. 2015 Nov;26(11):592-594. doi: 10.1016/j.tem.2015.09.002. Epub 2015 Oct 16. Review.

PMID:
26482875
22.

Metabolic Syndrome Sinkholes: What to Do When Occam's Razor Gets Blunted.

Feldman RD, Anderson TJ, Touyz RM.

Can J Cardiol. 2015 May;31(5):601-4. doi: 10.1016/j.cjca.2014.12.035. Epub 2015 Jan 12. Review.

PMID:
25936488
23.

The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Daskalopoulou SS, Rabi DM, Zarnke KB, Dasgupta K, Nerenberg K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, McKay DW, Tremblay G, McLean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Ramesh Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Brian Penner S, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Hiremath S, Stone JA, Drouin D, Lavoie KL, Hamet P, Fodor G, Grégoire JC, Fournier A, Lewanczuk R, Dresser GK, Sharma M, Reid D, Benoit G, Feber J, Harris KC, Poirier L, Padwal RS.

Can J Cardiol. 2015 May;31(5):549-68. doi: 10.1016/j.cjca.2015.02.016. Review.

PMID:
25936483
24.

G-protein estrogen receptor as a regulator of low-density lipoprotein cholesterol metabolism: cellular and population genetic studies.

Hussain Y, Ding Q, Connelly PW, Brunt JH, Ban MR, McIntyre AD, Huff MW, Gros R, Hegele RA, Feldman RD.

Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):213-21. doi: 10.1161/ATVBAHA.114.304326. Epub 2014 Nov 13.

PMID:
25395619
25.

Updated national and international hypertension guidelines: a review of current recommendations.

Kjeldsen S, Feldman RD, Lisheng L, Mourad JJ, Chiang CE, Zhang W, Wu Z, Li W, Williams B.

Drugs. 2014 Nov;74(17):2033-51. doi: 10.1007/s40265-014-0306-5. Review.

26.

Mineralocorticoids in the heart and vasculature: new insights for old hormones.

Lother A, Moser M, Bode C, Feldman RD, Hein L.

Annu Rev Pharmacol Toxicol. 2015;55:289-312. doi: 10.1146/annurev-pharmtox-010814-124302. Epub 2014 Sep 10. Review.

PMID:
25251996
27.

Intraclass differences among antihypertensive drugs.

Feldman RD, Hussain Y, Kuyper LM, McAlister FA, Padwal RS, Tobe SW.

Annu Rev Pharmacol Toxicol. 2015;55:333-52. doi: 10.1146/annurev-pharmtox-010814-124446. Epub 2014 Sep 22. Review.

PMID:
25251994
28.

GPER-independent effects of estrogen in rat aortic vascular endothelial cells.

Ding Q, Hussain Y, Chorazyczewski J, Gros R, Feldman RD.

Mol Cell Endocrinol. 2015 Jan 5;399:60-8. doi: 10.1016/j.mce.2014.07.023. Epub 2014 Aug 20.

PMID:
25150623
29.

A common hypofunctional genetic variant of GPER is associated with increased blood pressure in women.

Feldman RD, Gros R, Ding Q, Hussain Y, Ban MR, McIntyre AD, Hegele RA.

Br J Clin Pharmacol. 2014 Dec;78(6):1441-52. doi: 10.1111/bcp.12471.

30.

Increasing appreciation for the role of single-pill combinations for the prevention of atherosclerotic disease: a pro-polypill polemic.

Feldman RD, Nattel S.

Can J Cardiol. 2014 May;30(5):517-9. doi: 10.1016/j.cjca.2014.03.011. Epub 2014 Mar 14.

PMID:
24786441
31.

The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Dasgupta K, Quinn RR, Zarnke KB, Rabi DM, Ravani P, Daskalopoulou SS, Rabkin SW, Trudeau L, Feldman RD, Cloutier L, Prebtani A, Herman RJ, Bacon SL, Gilbert RE, Ruzicka M, McKay DW, Campbell TS, Grover S, Honos G, Schiffrin EL, Bolli P, Wilson TW, Lindsay P, Hill MD, Coutts SB, Gubitz G, Gelfer M, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Burns KD, Petrella RJ, Hiremath S, Milot A, Stone JA, Drouin D, Lavoie KL, Lamarre-Cliche M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk GB, Burgess E, Lewanczuk R, Dresser GK, Penner SB, Hegele RA, McFarlane PA, Khara M, Pipe A, Oh P, Selby P, Sharma M, Reid DJ, Tobe SW, Padwal RS, Poirier L; Canadian Hypertension Education Program.

Can J Cardiol. 2014 May;30(5):485-501. doi: 10.1016/j.cjca.2014.02.002. Epub 2014 Feb 22. Review.

32.

β-adrenoceptors as molecular targets in the treatment of hypertension.

Ferguson SS, Feldman RD.

Can J Cardiol. 2014 May;30(5 Suppl):S3-8. doi: 10.1016/j.cjca.2014.01.017. Epub 2014 Feb 12. Review.

33.

Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.

Khan NA, Herman RJ, Quinn RR, Rabkin SW, Ravani P, Tobe SW, Feldman RD, Wijeysundera HC, Padwal RS; Canadian Hypertension Education Program.

Can J Cardiol. 2014 Jan;30(1):16-21. doi: 10.1016/j.cjca.2013.07.008. Epub 2013 Oct 23. Review.

PMID:
24269056
34.

Aldosterone and blood pressure regulation: recent milestones on the long and winding road from electrocortin to KCNJ5, GPER, and beyond.

Feldman RD.

Hypertension. 2014 Jan;63(1):19-21. doi: 10.1161/HYPERTENSIONAHA.113.01251. Epub 2013 Nov 4. Review. No abstract available.

PMID:
24191283
35.

Vascular effects of aldosterone: sorting out the receptors and the ligands.

Feldman RD, Gros R.

Clin Exp Pharmacol Physiol. 2013 Dec;40(12):916-21. doi: 10.1111/1440-1681.12157. Review.

PMID:
23902478
36.

Simplified therapeutic intervention to control hypertension and hypercholesterolemia: a cluster randomized controlled trial (STITCH2).

Dresser GK, Nelson SA, Mahon JL, Zou G, Vandervoort MK, Wong CJ, Feagan BG, Feldman RD.

J Hypertens. 2013 Aug;31(8):1702-13. doi: 10.1097/HJH.0b013e3283619d6a.

PMID:
23743804
37.

From bad behaviour to bad biology: pitfalls and promises in the management of resistant hypertension.

Feldman RD, Brass EP.

Can J Cardiol. 2013 May;29(5):549-56. doi: 10.1016/j.cjca.2013.02.009. Review.

PMID:
23618504
38.

The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Hackam DG, Quinn RR, Ravani P, Rabi DM, Dasgupta K, Daskalopoulou SS, Khan NA, Herman RJ, Bacon SL, Cloutier L, Dawes M, Rabkin SW, Gilbert RE, Ruzicka M, McKay DW, Campbell TS, Grover S, Honos G, Schiffrin EL, Bolli P, Wilson TW, Feldman RD, Lindsay P, Hill MD, Gelfer M, Burns KD, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Milot A, Stone JA, Drouin D, Lavoie KL, Lamarre-Cliche M, Godwin M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk GB, Burgess E, Lewanczuk R, Dresser GK, Penner SB, Hegele RA, McFarlane PA, Sharma M, Reid DJ, Tobe SW, Poirier L, Padwal RS; Canadian Hypertension Education Program.

Can J Cardiol. 2013 May;29(5):528-42. doi: 10.1016/j.cjca.2013.01.005. Epub 2013 Mar 29.

PMID:
23541660
39.

High blood pressure selected as the theme for World Health Day, April 7, 2013: cup half full or half empty?

Campbell NR, Feldman RD, Kaczorowski J, Larochelle P.

Can J Cardiol. 2013 Apr;29(4):415-7. doi: 10.1016/j.cjca.2013.01.014. Epub 2013 Feb 28. No abstract available.

PMID:
23454039
40.

Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation.

Gros R, Ding Q, Liu B, Chorazyczewski J, Feldman RD.

Am J Physiol Cell Physiol. 2013 Mar;304(6):C532-40. doi: 10.1152/ajpcell.00203.2012. Epub 2013 Jan 2.

41.

Beyond the shadow: getting past the veil of nonadherence in the management of atherosclerotic risk factors.

Feldman RD, Campbell TS.

Can J Cardiol. 2012 Sep-Oct;28(5):531-3. doi: 10.1016/j.cjca.2012.07.005. No abstract available.

PMID:
22995192
42.

Hypertension management in patients with renal cell cancer treated with anti-angiogenic agents.

Larochelle P, Kollmannsberger C, Feldman RD, Schiffrin EL, Poirier L, Patenaude F, Ruether D, Myers M, Bjarnason G.

Curr Oncol. 2012 Aug;19(4):202-8. doi: 10.3747/co.19.972.

43.

Impact of age and gender on blood pressure and low-density lipoprotein cholesterol reduction: results of a pooled analysis.

Feldman RD, Flack J, Howes L, Jenssen T, Reeves R, Shi H, Westergaard M, Hobbs FD; GEMINI US, GEMINI AALA, JEWEL 1 and 2 and CAPABLE investigators.

Curr Med Res Opin. 2012 Sep;28(9):1421-33. Epub 2012 Aug 7.

PMID:
22809114
44.

The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

Daskalopoulou SS, Khan NA, Quinn RR, Ruzicka M, McKay DW, Hackam DG, Rabkin SW, Rabi DM, Gilbert RE, Padwal RS, Dawes M, Touyz RM, Campbell TS, Cloutier L, Grover S, Honos G, Herman RJ, Schiffrin EL, Bolli P, Wilson T, Feldman RD, Lindsay MP, Hemmelgarn BR, Hill MD, Gelfer M, Burns KD, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Bacon SL, Petrella RJ, Milot A, Stone JA, Drouin D, Lamarre-Cliché M, Godwin M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk G, Burgess E, Lewanczuk R, Dresser GK, Penner B, Hegele RA, McFarlane PA, Sharma M, Campbell NR, Reid D, Poirier L, Tobe SW; Canadian Hypertension Education Program.

Can J Cardiol. 2012 May;28(3):270-87. doi: 10.1016/j.cjca.2012.02.018. Review.

PMID:
22595447
45.

ACP Journal Club. Review: Home and clinic BP have limited accuracy compared with ambulatory BP for diagnosing hypertension.

Feldman RD.

Ann Intern Med. 2011 Dec 20;155(12):JC6-10. doi: 10.7326/0003-4819-155-12-201112200-02010. No abstract available.

PMID:
22184711
46.

Choreographing the adenylyl cyclase signalosome: sorting out the partners and the steps.

Ostrom RS, Bogard AS, Gros R, Feldman RD.

Naunyn Schmiedebergs Arch Pharmacol. 2012 Jan;385(1):5-12. doi: 10.1007/s00210-011-0696-9. Epub 2011 Oct 20. Review.

47.

miR-146a-Mediated extracellular matrix protein production in chronic diabetes complications.

Feng B, Chen S, McArthur K, Wu Y, Sen S, Ding Q, Feldman RD, Chakrabarti S.

Diabetes. 2011 Nov;60(11):2975-84. doi: 10.2337/db11-0478. Epub 2011 Sep 1.

48.

Delineating the receptor mechanisms underlying the rapid vascular contractile effects of aldosterone and estradiol.

Gros R, Ding Q, Davis M, Shaikh R, Liu B, Chorazyczewski J, Pickering JG, Feldman RD.

Can J Physiol Pharmacol. 2011 Sep;89(9):655-63. doi: 10.1139/Y11-062. Epub 2011 Aug 19.

PMID:
21854125
49.

The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

Rabi DM, Daskalopoulou SS, Padwal RS, Khan NA, Grover SA, Hackam DG, Myers MG, McKay DW, Quinn RR, Hemmelgarn BR, Cloutier L, Bolli P, Hill MD, Wilson T, Penner B, Burgess E, Lamarre-Cliché M, McLean D, Schiffrin EL, Honos G, Mann K, Tremblay G, Milot A, Chockalingam A, Rabkin SW, Dawes M, Touyz RM, Burns KD, Ruzicka M, Campbell NR, Vallée M, Prasad GV, Lebel M, Campbell TS, Lindsay MP, Herman RJ, Larochelle P, Feldman RD, Arnold JM, Moe GW, Howlett JG, Trudeau L, Bacon SL, Petrella RJ, Lewanczuk R, Stone JA, Drouin D, Boulanger JM, Sharma M, Hamet P, Fodor G, Dresser GK, Carruthers SG, Pylypchuk G, Gilbert RE, Leiter LA, Jones C, Ogilvie RI, Woo V, McFarlane PA, Hegele RA, Poirier L, Tobe SW; Canadian Hypertension Education Program.

Can J Cardiol. 2011 Jul-Aug;27(4):415-433.e1-2. doi: 10.1016/j.cjca.2011.03.015. English, French.

PMID:
21801975
50.

Competitive pricing and the challenge of cost control in medicare.

Coulam RF, Feldman RD, Dowd BE.

J Health Polit Policy Law. 2011 Aug;36(4):649-89. doi: 10.1215/03616878-1334677. Epub 2011 Jul 5.

PMID:
21730213

Supplemental Content

Loading ...
Support Center